Company profile CTMX

CytomX Therapeutics Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: November 05 2023 04:21:37.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
CytomX Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2018 - - - 0
2019 202
inf% QoQ
192
-5.0% QoQ
176
-8.3% QoQ
203
inf% YoY 15.3% QoQ
2020 262
29.7% YoY 29.1% QoQ
77
-59.9% YoY -70.6% QoQ
93
-47.2% YoY 20.8% QoQ
153
-24.6% YoY 64.5% QoQ
2021 129
-50.8% YoY -15.7% QoQ
56
-27.3% YoY -56.6% QoQ
146
57.0% YoY 160.7% QoQ
148
-3.3% YoY 1.4% QoQ
2022 56
-56.6% YoY -62.2% QoQ
145
158.9% YoY 158.9% QoQ
337
130.8% YoY 132.4% QoQ
207
39.9% YoY -38.6% QoQ
2023 127
126.8% YoY -38.6% QoQ
167
15.2% YoY 31.5% QoQ
212
-37.1% YoY 26.9% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and CytomX Therapeutics search interestLast update: November 05 2023 04:21:37.
Correlation coefficient between keyword and revenue is 0.24
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 04:21:38.

The average 5 years interest of CytomX Therapeutics was 11.88 per week.
The last year interest of CytomX Therapeutics compared to the last 5 years has changed by 3.96%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -11.15%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics cancer treatment to provide analysis

Correlation between past revenue and CytomX Therapeutics cancer treatment search interest

There is not enough data for CytomX Therapeutics cancer treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics cancer treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics Probody to provide analysis

Correlation between past revenue and CytomX Therapeutics Probody search interest

There is not enough data for CytomX Therapeutics Probody to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics Probody to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics CX-2009 to provide analysis

Correlation between past revenue and CytomX Therapeutics CX-2009 search interest

There is not enough data for CytomX Therapeutics CX-2009 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics CX-2009 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics CX-2029 to provide analysis

Correlation between past revenue and CytomX Therapeutics CX-2029 search interest

There is not enough data for CytomX Therapeutics CX-2029 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics CX-2029 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics stock price to provide analysis

Correlation between past revenue and CytomX Therapeutics stock price search interest

There is not enough data for CytomX Therapeutics stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics news to provide analysis

Correlation between past revenue and CytomX Therapeutics news search interest

There is not enough data for CytomX Therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics clinical trials to provide analysis

Correlation between past revenue and CytomX Therapeutics clinical trials search interest

There is not enough data for CytomX Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics careers to provide analysis

Correlation between past revenue and CytomX Therapeutics careers search interest

There is not enough data for CytomX Therapeutics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CytomX Therapeutics -stock -company to provide analysis

Correlation between past revenue and CytomX Therapeutics -stock -company search interest

There is not enough data for CytomX Therapeutics -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CytomX Therapeutics -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CTMX
Earnings date: 2024-02-28 After close
Company name: CytomX Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-11T11:24:26Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on CytomX Therapeutics, Lowers Price Target to $11

2026-05-07T20:15:00Z

GlobeNewswire
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

2026-04-30T12:00:00Z

GlobeNewswire
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

2026-03-23T16:51:26Z

Analyst Upgrades
Piper Sandler Maintains Overweight on CytomX Therapeutics, Raises Price Target to $12

2026-03-19T14:25:20Z

Analyst Upgrades
Barclays Maintains Overweight on CytomX Therapeutics, Raises Price Target to $16

2026-03-18T18:28:33Z

Analyst Upgrades
Jefferies Maintains Buy on CytomX Therapeutics, Raises Price Target to $16

2026-03-18T13:09:08Z

Analyst Upgrades
Guggenheim Maintains Buy on CytomX Therapeutics, Raises Price Target to $15

2026-03-17T12:33:20Z

Analyst Upgrades
Wedbush Maintains Outperform on CytomX Therapeutics, Raises Price Target to $11

2026-03-16T20:04:55Z

GlobeNewswire
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

2026-03-16T16:11:25Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on CytomX Therapeutics, Raises Price Target to $17

2026-03-16T15:37:28Z

Analyst Upgrades
JP Morgan Upgrades CytomX Therapeutics to Overweight, Raises Price Target to $12

2026-03-16T11:05:00Z

GlobeNewswire
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

2026-03-16T11:00:00Z

GlobeNewswire
CytomX's Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer

2026-03-16T05:25:50Z

Analyst Upgrades
CytomX Therapeutics Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

2026-03-09T13:12:36Z

Analyst Upgrades
Guggenheim Reiterates Buy on CytomX Therapeutics, Maintains $10 Price Target